Status and phase
Conditions
Treatments
About
The purpose of this study is to see if it is safe and effective to give Viracept to AIDS patients who are already being treated for cytomegalovirus (CMV) retinitis.
Sex
Ages
Volunteers
Inclusion and exclusion criteria
Inclusion Criteria
Patients must have:
Exclusion Criteria
Prior Medication:
Excluded:
Prior therapy (or less than 2 weeks) with protease inhibitor other than saquinavir.
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal